https://www.selleckchem.com/
associated with reduced risk of ICU admission compared to favipiravir alone in mild to moderate COVID-19 adult patients. Middle East Respiratory Syndrome Coronavirus (MERS-CoV) is associated with a high fatality rate (34%), which is higher in the presence of co-morbidities. The aim of the current study was to assess the clinical course and the outcome in hematological or oncological malignancy cases, diagnosed with MERS-CoV. This is a case series of hematological /oncological cases, diagnosed with MERS-CoV, in a tertiary care setting in 2015. The cases were
Gefällt mir
Kommentar
Teilen
